Clinical Trials in Drammen, Buskerud
13 recruiting
Showing 1–13 of 13 trials
Recruiting
Phase 3
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Merck Sharp & Dohme LLC780 enrolled260 locationsNCT06312137
Recruiting
Phase 3
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Merck Sharp & Dohme LLC1,530 enrolled288 locationsNCT06393374
Recruiting
Phase 3
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC868 enrolled229 locationsNCT06077760
Recruiting
Phase 2Phase 3
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Bristol-Myers Squibb596 enrolled186 locationsNCT07100080
Recruiting
Phase 3
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast NeoplasmsTriple Negative Breast NeoplasmsHR Low-Positive/HER2-Negative Breast Neoplasms
Merck Sharp & Dohme LLC2,400 enrolled268 locationsNCT06966700
Recruiting
Phase 3
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Bristol-Myers Squibb750 enrolled271 locationsNCT07361510
Recruiting
Phase 2Phase 3
A Study to Compare the Combination of BMS-986504 With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Bristol-Myers Squibb590 enrolled264 locationsNCT07063745
Recruiting
Phase 2
D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression
Haukeland University Hospital100 enrolled11 locationsNCT07312110
Recruiting
Not Applicable
The Norwegian World Health Organisation Labour Care Guide Trial (NORWEL)
ProgressionExperience, LifeLabor (Obstetrics)--Complications+5 more
Ostfold Hospital Trust23,650 enrolled10 locationsNCT05791630
Recruiting
Health-Related Quality of Life in Children and Adolescents With Clubfoot
ClubfootChildrenHRQOL (Health Related Quality Of Life)
Vestre Viken Hospital Trust30 enrolled1 locationNCT06906406
Recruiting
Not Applicable
Digital Secondary Prevention After Atherosclerotic Cardiovascular Disease
Atheroscleroses, CoronaryAtheroscleroses, CerebralAtherosclerotic Ischemic Disease
Vestre Viken Hospital Trust300 enrolled1 locationNCT06738381
Recruiting
Not Applicable
Cognitive Behavioural Therapy for Insomnia in Patients With Coronary Heart Disease
Coronary Heart DiseaseInsomnia Chronic
Vestre Viken Hospital Trust76 enrolled1 locationNCT06749951
Recruiting
The Norwegian Antirheumatic Drug Register
Inflammatory Joint Diseases
Diakonhjemmet Hospital15,000 enrolled6 locationsNCT01581294